[{"address1": "455 Mission Bay Boulevard South", "city": "San Francisco", "state": "CA", "zip": "94158", "country": "United States", "phone": "415 482 5300", "fax": "415 339 5300", "website": "https://www.nektar.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally. It develops NKTR-358, a regulatory T (Treg) cell stimulator designed to address the imbalance in the immune system underlying autoimmune disorders and chronic inflammatory conditions; PEG-CSF1, a polyethylene glycol (PEG) modified hematopoietic colony stimulating factor protein that is engineered to selectively modulate resolution processes of inflammation and has applications in a number of therapeutic indications, including acute and chronic inflammation; Tumor necrosis factor (TNF) receptor type II (TNFR2) agonist asset is a bivalent antibody molecule used to selectively stimulate TNFR2 receptor activity, without modulation of the TNFR1 signaling; and NKTR-255, an IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.", "fullTimeEmployees": 61, "companyOfficers": [{"maxAge": 1, "name": "Mr. Howard W. Robin", "age": 72, "title": "CEO, President & Director", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 2166571, "exercisedValue": 0, "unexercisedValue": 186333}, {"maxAge": 1, "name": "Ms. Sandra A. Gardiner", "age": 59, "title": "CFO and Principal Financial & Accounting Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 460850, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jonathan  Zalevsky Ph.D.", "age": 49, "title": "Senior VP and Chief Research & Development Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 1151200, "exercisedValue": 0, "unexercisedValue": 35833}, {"maxAge": 1, "name": "Mr. Jason  Barnard", "title": "Chief Accounting Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth  Zhang", "title": "VP of Legal & Corporate Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Bacci", "title": "Chief People Officer and Head of Quality & Facilities", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Ruddock", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mary  Tagliaferri L.Ac., M.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ken  Franke Ph.D.", "title": "Senior Vice President of Biologics Process Development & Manufacturing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Charleen  Jue", "title": "Senior Vice President of Clinical Development Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 2, "overallRisk": 5, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.nektar.com/", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 73.86, "open": 73.8602, "dayLow": 71.504, "dayHigh": 74.83, "regularMarketPreviousClose": 73.86, "regularMarketOpen": 73.8602, "regularMarketDayLow": 71.504, "regularMarketDayHigh": 74.83, "payoutRatio": 0.0, "beta": 1.335, "forwardPE": -6.288273, "volume": 994249, "regularMarketVolume": 994249, "averageVolume": 1062546, "averageVolume10days": 2334060, "averageDailyVolume10Day": 2334060, "bid": 61.92, "ask": 84.08, "bidSize": 1, "askSize": 1, "marketCap": 2062930048, "fiftyTwoWeekLow": 6.45, "fiftyTwoWeekHigh": 74.83, "allTimeHigh": 1670.4, "allTimeLow": 6.15, "priceToSalesTrailing12Months": 32.954155, "fiftyDayAverage": 45.0424, "twoHundredDayAverage": 37.33625, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1396656384, "profitMargins": -1.9286901, "floatShares": 19077156, "sharesOutstanding": 27979520, "sharesShort": 3287467, "sharesShortPriorMonth": 2935715, "sharesShortPreviousMonthDate": 1767139200, "dateShortInterest": 1769731200, "sharesPercentSharesOut": 0.1616, "heldPercentInsiders": 0.0062, "heldPercentInstitutions": 0.63917, "shortRatio": 4.5, "shortPercentOfFloat": 0.16459998, "impliedSharesOutstanding": 27979521, "bookValue": 4.33, "priceToBook": 17.027714, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -120736000, "trailingEps": -9.83, "forwardEps": -11.725, "lastSplitFactor": "1:15", "lastSplitDate": 1749427200, "enterpriseToRevenue": 22.311, "enterpriseToEbitda": -10.331, "52WeekChange": 3.4861636, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 73.73, "targetHighPrice": 165.0, "targetLowPrice": 102.0, "targetMeanPrice": 129.85715, "targetMedianPrice": 121.0, "recommendationMean": 1.125, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 270208000, "totalCashPerShare": 13.284, "ebitda": -135195008, "totalDebt": 167079008, "quickRatio": 4.093, "currentRatio": 4.241, "totalRevenue": 62600000, "debtToEquity": 196.365, "revenuePerShare": 4.096, "returnOnAssets": -0.27975, "returnOnEquity": -1.8024299, "grossProfits": 54623000, "freeCashflow": -57101876, "operatingCashflow": -189739008, "revenueGrowth": -0.511, "grossMargins": 0.87257004, "ebitdaMargins": -2.15966, "operatingMargins": -2.67447, "financialCurrency": "USD", "symbol": "NKTR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1771631733, "regularMarketTime": 1771621200, "exchange": "NCM", "messageBoardId": "finmb_29929", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.176005, "regularMarketPrice": 73.73, "fiftyDayAverageChange": 28.687603, "fiftyDayAverageChangePercent": 0.63690215, "twoHundredDayAverageChange": 36.393753, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.1 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 767971800000, "postMarketChangePercent": -1.8445687, "postMarketPrice": 72.37, "postMarketChange": -1.3600006, "regularMarketChange": -0.129997, "regularMarketDayRange": "71.504 - 74.83", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1062546, "fiftyTwoWeekLowChange": 67.28001, "fiftyTwoWeekLowChangePercent": 10.431009, "fiftyTwoWeekRange": "6.45 - 74.83", "fiftyTwoWeekHighChange": -1.0999985, "fiftyTwoWeekHighChangePercent": -0.014699966, "fiftyTwoWeekChangePercent": 348.61636, "earningsTimestampStart": 1773262800, "earningsTimestampEnd": 1773262800, "earningsCallTimestampStart": 1762466400, "earningsCallTimestampEnd": 1762466400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -9.83, "epsForward": -11.725, "epsCurrentYear": -9.37, "priceEpsCurrentYear": -7.8687305, "twoHundredDayAverageChangePercent": 0.97475654, "marketState": "CLOSED", "shortName": "Nektar Therapeutics", "longName": "Nektar Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]